Skip to content

AFAQ SHAFEEQ – TEST & VALIDATION ENGINEER

By bertrand

AFAQ SHAFEEQ – TEST & VALIDATION ENGINEER August 03, 2021 Afaq Shafeeq joins Cardiawave last month as a Test & Validation Engineer. Before, Afaq occupied the position of IT Front office solutions trainee at Pernot Ricard for six months after having graduated from Esigelec.  Welcome on board! 

CLINICAL STUDY IN HEGP – JULY 2021

By bertrand

CLINICAL STUDY IN HEGP – JULY 2021 July 28, 2021 One patient suffering from severe symptomatic Aortic Stenosis was successfully treated last week in France at the Hôpital Européen Georges-Pompidou (AP-HP, Assistance Publique – Hôpitaux de Paris). Congratulations and thanks to Prof. Emmanuel Messas and HEGP team!

LOIC RAZAFILAHY – BIOMEDICAL ENGINEER

By bertrand

LOIC RAZAFILAHY – BIOMEDICAL ENGINEER July 01, 2021 Loic Razafilahy is a Biomedical Engineer from Polytech Lyon who joins Cardiawave as a Software Engineer in Test, pursuing his previous career experiences in the MedTech. Welcome on board ! 

VIDEO OF CARDIAWAVE INNOVATIVE THERAPY

By bertrand

VIDEO OF CARDIAWAVE INNOVATIVE THERAPY June 22, 2021 Thanks Xavier Granet for your great video! You have enlightened Cardiawave innovative non-invasive ultrasound therapy investigational device for the treatment of calcific aortic stenosis.

2021 ACCELERATOR & SHOWCASE COHORT

By bertrand

2021 ACCELERATOR & SHOWCASE COHORT June 18, 2021 Cardiawave has been selected to participate in MedTech Innovator’s flagship Showcase and Accelerator program! Out of over a thousand applicants, Cardiawave was one of the 50 selected startups featuring the most promising medical innovations. We want to thank Medtech Innovator organisers and AdvaMed for this opportunity, it is a real pleasure for … Continued

1ER SYMPOSIUM HIFUTURE

By bertrand

1ER SYMPOSIUM HIFUTURE June 17, 2021 Cardiawave est présente actuellement au 1er Symposium HIFUture du 17 au 18 juin à Lyon pour promouvoir sa thérapie révolutionnaire non-invasive par ultrasons pour traiter la sténose aortique. C’est une opportunité pour Cardiawave de rencontrer des ingénieurs, cliniciens et industriels impliqués en France dans les traitements thérapeutiques par ultrasons. 

CLINICAL STUDY IN BREDA– JUNE 2021

By bertrand

CLINICAL STUDY IN HEGP – JUNE 2021 June 15, 2021 One more patient affected by severe symptomatic Aortic Stenosis was treated, and one was retreated early June with Cardiawave non-invasive ultrasound therapy investigational device in Breda, The Netherlands. Congratulations to Dr. Sander IJsselmuiden and Amphia Hospital Teams! 

STUDY BY PUBMED

By bertrand

STUDY – PUBMED June 10, 2021 Thanks David Smadja and HEGP team for the study about “Von Willebrand factor multimers during non-invasive ultrasound therapy for aortic valve stenosis”. For more information: bit.ly/3cqwrnu 

INTERNATIONAL SYMPOSIUM FOR THERAPEUTIC ULTRASOUND

By bertrand

INTERNATIONAL SYMPOSIUM FOR THERAPEUTIC ULTRASOUND June 08, 2021 Cardiawave is attending the 20th Annual International Symposium for Therapeutic Ultrasound (ISTU 2021) from June 6-9. Daniel Suarez Escudero will be presenting on June 09 at 09:00 KST the 12-month results of our First-in-Human Study. You can attend his session here: https://lnkd.in/dwHC3nv (only registered members can attend).

TAYLOR & FRANCIS GROUP

By bertrand

TAYLOR & FRANCIS GROUP May 25 2021 Thank you Zhen Xu, Timothy Hall, Eli Vlaisavljevich and Fred T. Lee Jr. for quoting Cardiawave’s Non-Invasive Ultrasound Therapy (NIUT) to treat severe symptomatic calcific aortic stenosis in the article published in Taylor & Francis Group entitled “Histotripsy: the first non-invasive, non-ionizing, non-thermal ablation technique based on ultrasound”.